U.S. federal trademark · Serial No. 87328149
Blood-based diagnostic medical genomic testing to determine which cancer patients harbor mutations or other anomalies that are typically treated with targeted therapies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.